PureTech LYT, Inc.
6Patents
6Active
6Granted
51Portfolio score
Filing activity: Aug 29, 2018 → Jun 26, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11304954B2 | Lipid prodrugs of mycophenolic acid and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11883497B2 | Lymphatic system-directing lipid prodrugs | Chemistry; Metallurgy | 1 | Active |
| US11938137B2 | Lipid prodrugs of mycophenolic acid and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12084500B2 | Antibodies specific to delta 1 chain of T cell receptor | Chemistry; Metallurgy | 0 | Active |
| US11975073B2 | Lipid prodrugs of neurosteroids | Chemistry; Metallurgy | 0 | Active |
| US11608345B1 | Lipid prodrugs of rapamycin and its analogs and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.